Apogee Therapeutics, Inc. Share Price
Stocks
APGE
US03770N1019
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 03/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 135.07 USD | -0.01% |
|
+0.07% | +78.95% |
| 03/09 | AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics | MT |
| 03/09 | Apogee Therapeutics, Inc.(NasdaqGM:APGE) dropped from S&P Biotechnology Select Industry Index | CI |
| Market Cap | 1.02TCr 876.54Cr 824.7Cr 753.36Cr 1.41TCr 96TCr 1.41TCr 9.75TCr 3.78TCr 49TCr 3.83TCr 3.74TCr 1,59000Cr | P/E 2026 * |
-28.1x | P/E 2027 * | -22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 922.48Cr 793.8Cr 746.85Cr 682.25Cr 1.28TCr 87TCr 1.28TCr 8.83TCr 3.42TCr 45TCr 3.46TCr 3.39TCr 1,44000Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 1,324x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| APGE | Delayed | |
CBOE
| APGE | Real-time |
Last Transcript : Apogee Therapeutics, Inc.
| 1 day | -0.01% | ||
| 1 week | +0.07% | ||
| Current month | -0.01% | ||
| 1 month | +0.66% | ||
| 3 months | +48.59% | ||
| 6 months | +86.79% | ||
| Current year | +78.95% |
| 1 week | 134.99 |  | 135.09 |
| 1 month | 134.25 | | 135.09 |
| Current year | 60.35 | | 135.09 |
| 1 year | 35.39 | | 135.09 |
| 3 years | 14.19 | | 135.09 |
| 5 years | 14.19 | | 135.09 |
| 10 years | 14.19 | | 135.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 36 | 01/09/2022 | |
Jane Henderson
DFI | Director of Finance/CFO | 60 | 01/01/2023 |
Tim Piringer
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jennifer Fox
BRD | Director/Board Member | 54 | 22/06/2023 |
William Jones
BRD | Director/Board Member | 62 | 01/06/2023 |
| Director/Board Member | 36 | 01/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/08/26 | Fairmount Funds Management LLC
| Exercice | Company | 84,416 | 0.1507% | |
| 07/08/26 | Other | Director | 0 | 0% | ||
| 07/08/26 | Other | Director | 0 | 0% | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | +0.07% | +263.78% | +446.62% | 1.02TCr | |
| -2.54% | -2.84% | -1.90% | +14.52% | 4.89TCr | |
| -0.40% | +1.03% | +439.20% | +499.20% | 4.5TCr | |
| -1.42% | +2.30% | +45.46% | +19.36% | 4.41TCr | |
| -1.22% | -2.31% | +12.40% | +71.48% | 4.07TCr | |
| +0.53% | -1.36% | +16.04% | +48.23% | 3.35TCr | |
| -0.21% | +9.14% | - | - | 1.78TCr | |
| -0.35% | -1.56% | +22.59% | +116.19% | 1.65TCr | |
| -1.01% | +0.50% | +15.83% | +27.98% | 1.47TCr | |
| -1.65% | -1.03% | +77.75% | +37.63% | 1.38TCr | |
| Average | -0.83% | +0.49% | +99.02% | +142.36% | 2.85TCr | |
| Weighted average by Cap. | -1.00% | +0.11% | +101.29% | +134.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 71.43L 61.46L 57.83L 52.83L 98.82L 67Cr 99.09L 6.83Cr 2.65Cr 35Cr 2.68Cr 2.62Cr 111.47Cr |
| Net income | -35Cr -30Cr -28Cr -26Cr -48Cr -3.29TCr -48Cr -333.13Cr -129.27Cr -1.69TCr -130.76Cr -127.9Cr -5.43TCr | -47Cr -40Cr -38Cr -35Cr -65Cr -4.42TCr -65Cr -447.71Cr -173.73Cr -2.27TCr -175.73Cr -171.9Cr -7.3TCr |
| Net Debt | -96Cr -83Cr -78Cr -71Cr -133.03Cr -9.08TCr -133.39Cr -919.87Cr -356.95Cr -4.66TCr -361.06Cr -353.18Cr -15TCr | -73Cr -63Cr -59Cr -54Cr -101.17Cr -6.9TCr -101.44Cr -699.57Cr -271.47Cr -3.54TCr -274.59Cr -268.6Cr -11TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $135.07 | -0.01% | 51,42,068 |
| 01/26/01 | $135.08 | 0.00% | 10,90,742 |
| 31/26/31 | $135.08 | +0.08% | 18,11,685 |
| 28/26/28 | $134.97 | +0.01% | 7,33,857 |
| 27/26/27 | $134.96 | +0.01% | 11,37,230 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- APGE Stock
Select your edition
All financial news and data tailored to specific country editions
